219 completed, 16 unknown, 6 active not recruiting, 6 recruiting. 125 Phase 3, 55 Phase 4, 35 Phase 2, 16 Phase 1, 11 Not applicable.
Follow Corynebacterium Infections: new trials by email Literature Review of Corynebacterium Infections trials Research Report on Corynebacterium Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study on Immunogenicity Persistence of Adsorbed 5-component Acellular Pertussis, Diphtheria and Tetanus Combined Vaccine Previously received the Tdcp vaccine at age 18 and older, Previously received the Tdcp vaccine at age 12-17, Previously received the Tdcp vaccine at age 6-11 - Diphtheria, Tetanus | Not yet recruiting | CanSino Biologics Inc. | 160 | 2026-10-15 | 2026-08-04 | |
| A Phase I/II Clinical Trial of the Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine Adsorbed Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine Adsorbed, Diphtheria, Tetanus and Acellular Component Pertussis Combined Vaccine, Diphtheria, Tetanus and Acellular Component Pertussis Combined Vaccine+Inactivated Poliomyelitis Vaccine Made From Sabin Strains - Diphtheria, Pertussis | Phase 1 / Phase 2 | Recruiting | Institute of Medical Biology, Chinese Academy of Medical Sciences | 380 | 2026-10-11 | 2026-10-23 |
| Study of BK1803 in Healthy Infants BK1803, GOBIK Aqueous Suspension Syringes, Bimmugen® Injection - Pertussis, Diphtheria | Phase 3 | Not yet recruiting | Tanabe Pharma Corporation | 344 | 2026-10-01 | 2026-08-28 |
| A Phase II Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) Tdap vaccine, Placebo - Pertussis (Whooping Cough), Diphtheria | Phase 2 | Recruiting | Changchun BCHT Biotechnology Co. | 420 | 2026-08-12 | 2026-10-26 |
| A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant Women dTpa - Diphtheria-Tetanus-acellular Pertussis Vaccines | Phase 3 | Active not recruiting | GlaxoSmithKline | 102 | 2026-06-29 | 2026-09-08 |
| Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months Old Maternal TdaP2gen vaccine, Infant Acellular Pertussis-containing Vaccine, Infant Whole-cell Pertussis-containing Vaccine - Pertussis, Diphtheria | Phase 4 | Not yet recruiting | Chiang Mai University | 320 | 2026-05-26 | 2026-06-02 |
| A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) Tdap vaccine - Pertussis (Whooping Cough), Diphtheria | Phase 1 | Not yet recruiting | Changchun BCHT Biotechnology Co. | 96 | 2026-04-20 | 2026-03-25 |
| Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine low-dose Tetanus, Diphtheria and Acellular Component Pertussis Vaccine Adsorbed (Reduced Antigens Content), high-dose Tetanus, Diphtheria and Acellular Component Pertussis Vaccine Adsorbed (Reduced Antigens Content), Tetanus, Diphtheria and Acellular Pertussis Vaccine - Tetanus, Diphtheria and Acellular Pertussis Vaccination, Tetanus | Phase 1 / Phase 2 | Not yet recruiting | Institute of Medical Biology, Chinese Academy of Medical Sciences | 660 | 2026-03-12 | 2026-02-18 |
| Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial Influenza and Tdap Vaccination Educational and Learning Module - Vaccination Uptake, Knowledge | Not applicable | Recruiting | Universiti Putra Malaysia | 351 | 2026-01-13 | 2026-05-01 |
| Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine Adsorbed Acellular Pertussis (3-Component) Diphtheria-Tetanus-Pertussis-Haemophilus influenzae type b (Conjugate)-Meningococcal Group ACYW135 (Conjugate) Combined Vaccine (DTcP-Hib-MCV4), DTcP-Hib-MCV4, Adsorbed Acellular Pertussis (3-Component) Diphtheria-Tetanus-Pertussis (DTcP) - Diphtheria, Tetanus and Acellular Pertussis, Epidemic Meningitis | Phase 1 | Recruiting | CanSino Biologics Inc. | 260 | 2025-12-19 | 2025-12-31 |
| Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy Tdap Vaccine Administration, RSV Vaccine, Saline (as a placebo) - RSV, Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination | Phase 4 | Recruiting | Canadian Immunization Research Network | 60 | 2025-10-16 | 2026-10-22 |
| A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series LBVD, Pentavalent vaccine and Inactivated Polio vaccine - Diphtheria, Tetanus | Phase 2 / Phase 3 | Active not recruiting | LG Chem | 1186 | 2025-05-30 | 2026-09-03 |
| Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 1), Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 2), Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 3) - Diphtheria, Tetanus and Acellular Pertussis | Phase 3 | Active not recruiting | CanSino Biologics Inc. | 780 | 2025-03-23 | 2025-08-15 |
| A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Tdcp)), 23-valent Pneumococcal Polysaccharide Vaccine (PPV23), Tdcp - Diphtheria, Tetanus | Phase 2 / Phase 3 | Completed | CanSino Biologics Inc. | 1820 | 2024-12-20 | 2026-08-26 |
| PFAS Exposure and Immune Response to Vaccination in Adults TENIVAC - Innate Inflammatory Response, Vaccination | Phase 4 | Completed | Rutgers, The State University of New Jersey | 20 | 2024-11-04 | 2025-12-30 |
| Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age LR20062, DTaP-HepB-IPV-Hib vaccine - Diphtheria, Tetanus | Phase 2 | Unknown | LG Chem | 336 | 2024-10-02 | 2024-10-01 |
| Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants Different immunization regiments with DTaP-IPV/Hib Pentavalent Vaccine - Pertussis, Diphtheria | Not applicable | Unknown | Jiangsu Province Centers for Disease Control and Prevention | 785 | 2024-09-05 | 2024-09-20 |
| Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy Education, Vaccine administration - Non-birthing Partner Vaccination in Pregnancy, Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination | Phase 4 | Unknown | Women and Infants Hospital of Rhode Island | 150 | 2024-05-28 | 2024-09-20 |
| Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance Cellular immunity vs SARS-CoV-2, Humoral immunity vs SARS-CoV-2, Cellular immunity vs Varicella Zoster Virus - Follicular Lymphoma | Active not recruiting | Fondazione Italiana Linfomi - ETS | 56 | 2024-05-07 | 2026-06-26 | |
| Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine DTacP (one-dose booster), DTacP (three-dose primary vaccination), DT (one-dose booster) - Diphtheria, Tetanus | Phase 1 | Recruiting | Institute of Medical Biology, Chinese Academy of Medical Sciences | 460 | 2023-12-23 | 2024-01-03 |
Showing 20 of 257. Sign in to see all of them.
Diphtheria (256) · Tetanus (244) · Whooping Cough (161) · Poliomyelitis (114) · Haemophilus Infections (107) · Hepatitis B (101) · Influenza, Human (7) · Measles (7) · Virus Diseases (7) · Meningococcal Infections (6) · Pneumococcal Infections (6) · Meningitis, Meningococcal (5) · Bacterial Infections (4) · Meningitis (3) · COVID-19 (2)
Actinomycetales Infections (257) · Bacterial Infections and Mycoses (257) · Gram-Positive Bacterial Infections (257) · Infections (256) · Bacterial Infections (253) · Clostridium Infections (244) · Gram-Negative Bacterial Infections (202) · Respiratory Tract Diseases (166) · Respiratory Tract Infections (165) · Bordetella Infections (161) · Virus Diseases (149) · RNA Virus Infections (124) · Nervous System Diseases (122) · Neuroinflammatory Diseases (121)
Tetanus Toxoid (51) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (29) · Boostrix (25) · Diphtheria-Tetanus-acellular Pertussis Vaccines (24) · adacel (22) · Pentavac (13) · Vaccines, Combined (11) · DTaP-IPV-HB-PRP-T vaccine (10) · Hiberix (10) · pentacel (10) · 13-valent pneumococcal vaccine (9) · Heptavalent Pneumococcal Conjugate Vaccine (8) · Poliovirus Vaccine, Inactivated (8) · Diphtheria-Tetanus Vaccine (7) · Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (6)
GlaxoSmithKline (97) · Sanofi Pasteur, a Sanofi Company (58) · Sanofi (18) · CanSino Biologics Inc. (7) · LG Chem (7) · Merck Sharp & Dohme LLC (7) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · Crucell Holland BV (3) · Institute of Medical Biology, Chinese Academy of Medical Sciences (3) · Shantha Biotechnics Limited (3) · Tanabe Pharma Corporation (3) · Boryung Biopharma Co., Ltd. (2) · Changchun BCHT Biotechnology Co. (2) · Green Cross Corporation (2) · MCM Vaccines B.V. (2)
United States (46) · China (26) · South Korea (17) · Philippines (16) · Canada (14) · Germany (14) · Thailand (12) · Finland (9) · France (9) · India (9) · Japan (8) · Italy (7) · Spain (7) · Russia (6) · Vietnam (6)
Raman Rao, MD (3) · Eva Netterlid (2) · Maria RZ Capeding, MD (2) · Yanxia Wang (2) · Abdul M Kazi, MBBS,MPH (1) · Adam Thaler, DO (1) · Aleksandra Banaszkiewicz, MD, PhD (1) · Alison Connor, PhD (1) · Anne Fiquet, MD (1) · Bahaa Abu-Raya, M.D., PhD (1)
PMID 17716936, PMID 25882172, PMID 28340322, PMID 15882526, PMID 16511379, PMID 17090650, PMID 19095033, PMID 19117896, PMID 19952980, PMID 20439595, PMID 20448468, PMID 20616762, PMID 20657177, PMID 20950456, PMID 20955461, PMID 21134450, PMID 21219984, PMID 21289531, PMID 21334243, PMID 21372751, PMID 21441781, PMID 21807056, PMID 21945698, PMID 22001281, PMID 22115634, PMID 22157567, PMID 22273029, PMID 22349525, PMID 22475857, PMID 22531237, PMID 22691430, PMID 23077849, PMID 23241989, PMID 23783081, PMID 23966556, PMID 24176498, PMID 24346596, PMID 24794369, PMID 24835247, PMID 25008903, PMID 25230939, PMID 25540274, PMID 25613716, PMID 25765966, PMID 26057135, PMID 26075317, PMID 27288217, PMID 27373595, PMID 27510380, PMID 27846055
2014 (3), 2015 (2), 2008 (1), 2009 (1), 2016 (1), 2018 (1), 2019 (1), R21AI141822 (1)